SEARCH

SEARCH BY CITATION

Data S1. Methods.

Figure S1. Graphic representation of the expression levels of PI3K/AKT/mTOR and MAPK pathways effectors in cutaneous melanomas and nevi.

Table S1. Clinico-pathological features of cutaneous melanomas.

Table S2. Description of the antibodies used.

FilenameFormatSizeDescription
PCMR_796_sm_AppS1.doc86KSupporting info item
PCMR_796_sm_FigS1.TIF57KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.